An Observational Study on the Safety and Efficacy of Henagliflozin in Chinese Patients With Type 2 Diabetes

RecruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

June 19, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2026

Conditions
Type 2 Diabetes Mellitus (T2DM)
Interventions
OTHER

No Intervention: Observational Cohort

Observation study

Trial Locations (7)

Unknown

NOT_YET_RECRUITING

The People's Hospital of Beihai, Beihai

NOT_YET_RECRUITING

Guilin Municipal Hospital of Traditional Chinese Medicine, Guilin

NOT_YET_RECRUITING

Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Nanning

NOT_YET_RECRUITING

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

NOT_YET_RECRUITING

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

RECRUITING

the Second Affiliated Hospital of Guangxi Medical University, Nanning

NOT_YET_RECRUITING

Qingdao Aikangyi Internet Hospital, Qingdao

All Listed Sponsors
lead

Second Affiliated Hospital of Guangxi Medical University

OTHER